RNS Number : 5367A
Sivota PLC
26 September 2022
 

 

26 September 2022

 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION REGARDING SIVOTA PLC.  NOTHING IN THIS ANNOUNCEMENT OR THE PROSPECTUS CONSTITUTES AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY TERRITORY.

 

SIVOTA PLC

("Sivota," or "the Company")

 

Readmission of the entire issued Ordinary Share capital to the Official List (by way of a Standard Listing under Chapter 14 of the Listing Rules) and to trading on the London Stock Exchange's Main Market for listed securities

Further to the announcement of 22 September 2022, the board of Sivota is pleased to announce the readmission of its entire issued share capital, being 12,585,000 ordinary shares of £0.01 each to the Official List (by way of a Standard Listing under Chapter 14 of the Listing Rules) and to trading on the London Stock Exchange's Main Market for listed securities.

For further information, please visit www.sivotacapital.com or contact:

Sivota PLC

Tim Weller, Non-Executive Chairman

Ziv Ben-Barouch, Chief Executive Officer

 

via Vigo Consulting

Canaccord Genuity Limited

Alex Aylen - Head of Equities

 

+ 44 (0) 20 7523 8000

Vigo Consulting

Jeremy Garcia

+ 44 (0)20 7390 0230

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVVNRUVUKUAR